Stocks and securities in focus
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Resmed Inc. | 1.810% | 1.730% | -3.720% | -5.822% | 23.828% | 14.988% | 90.294% |
Insmed Inc. | 0.990% | 23.171% | 113.983% | 182.123% | 76.573% | 145.146% | 147.307% |
United Therapeutics | 0.240% | 1.332% | 3.037% | 23.817% | 26.658% | 73.172% | 237.545% |
Viking Therapeutics Inc | 0.230% | -14.153% | -27.700% | 148.462% | 195.568% | 1094.637% | - |
ImmunityBio Inc. | -0.390% | -7.028% | -33.137% | 117.769% | 19.958% | -60.686% | - |
G1 Therapeutics | -3.380% | -6.378% | -29.014% | 20.328% | 6.764% | -83.112% | - |
Cardiff Oncology Inc. | -4.130% | -6.208% | -14.395% | 89.620% | 112.386% | -55.635% | -20.143% |
Cytomx Therapeutics Inc | -4.810% | -6.292% | -62.439% | -3.908% | 10.960% | -72.240% | - |
Fibrogen Inc. | -7.770% | 0.139% | 2.418% | -93.571% | 25.581% | -93.795% | - |